Verde Science Inc. (VRCI)

[Deleted123]

Verde Science Announces Plan to Study Cannabis Preparation for Treatment of Huntingdon's Disease
GlobeNewswire
1:15 PM ET
Verde Science, Inc. (OTCQB:VRCI), a Pharmaceutical Research and Development Company focused on developing a portfolio of cannabinoid based prescription medicines to meet patients' needs for a wide range of medical conditions, is pleased to announce that along with some renowned research scientists it intends to study the treatment potential of a cannabis preparation (Nabiximols) in the treatment of Huntingdon's Disease as a sponsor at 2 universities in North America. The study as currently designed will be a double-blind, placebo controlled protocol with 48 subjects.

Harp Sangha, CEO of Verde Science commented, "We will be embarking on our first research study into the potential of cannabis preparations to treat medical conditions and improve lives. Our team is excit ed to approach this milestone and is hopeful that it will lead to an efficacious and commercially viable pharmaceutical product and additional research studies for treating other medical conditions."

$VRCI